Transthyretin Amyloidosis

Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis

The Eplontersen Pregnancy and Lactation Outcomes Study

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

Monitoring of Early Disease Progression in Hereditary Transthyretin Amyloidosis

ATTRACT-52: Primary Care Cardiac Amyloidosis Screening in Ordu, Turkey

Spectrum of Peripheral and Autonomic Neuropathies in Patients With aTTRwt Amyloidosis and Response to Patisiran Therapy

HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)

Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

Prevalence of wtATTR-CM After Carpal Tunnel Release Surgery

Phenotyping and Characterization of wtATTR-CM (TRACE 1)

Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR

TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects

Retrospective Identification of Scintigraphic Cardiac Amyloidosis (RISCA)

Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

PL_GNT01_ISR_Grant 53234273

Transthyretin Amyloidosis Outcome Survey (THAOS)

Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy